DP-b99

DRUG3 trials

Sponsors

D-Pharm Ltd.

Conditions

Acute Ischemic StrokeBrain IschemiaCerebrovascular DisordersPancreatitisStroke

Phase 2

Effects Of DP-b99 On Neurological Function In Subjects With Acute Ischemic Hemispheric Stroke

CompletedNCT00190047

D-Pharm Ltd.Brain Ischemia, Cerebrovascular Disorders, Stroke

Start: 2005-02-28End: 2006-10-31Target: 150Updated: 2007-11-26

DP-b99 in the Treatment of Acute High-risk Pancreatitis

TerminatedNCT02025049

D-Pharm Ltd.Pancreatitis

Start: 2013-12-31End: 2015-05-31Updated: 2015-06-23

Phase 3

Efficacy and Safety Study of DP-b99 in Treating Acute Ischemic Stroke

TerminatedNCT00893867

D-Pharm Ltd.Acute Ischemic Stroke

Start: 2009-12-31End: 2012-04-30Updated: 2012-10-24

Related Papers

Results of Membrane-Activated Chelator Stroke Intervention randomized trial of DP-b99 in acute ischemic stroke.

2013-02-0722 citations